Need professional-grade analysis? Visit stockanalysis.com
$375.00B
47.74
20,602
0.35%
Jiangsu Hengrui Medicine Co Ltd (600276) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY56.33, down 1.98% from the previous close.
Over the past year, 600276 has traded between a low of CNY49.17 and a high of CNY72.47. The stock has gained 14.6% over this period. It is currently 22.3% below its 52-week high.
Jiangsu Hengrui Medicine Co Ltd has a market capitalization of $375.00B, with a price-to-earnings ratio of 47.74 and a dividend yield of 0.35%.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Side-by-side comparison against top Healthcare peers.